Discovery could lead to better asthma treatment

April 21, 2016
Obstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale Rosen/Wikipedia/CC BY-SA 2.0

Scientists have made a discovery that could lead to improved treatment for asthma sufferers.

They have found that blocking a certain signalling molecule can alleviate symptoms such as , swelling (edema), and constriction of the airways in the lungs.

The international study, led by Dr Stephan Caucheteux, from Cardiff University's School of Medicine, believes their work could ultimately help around the world.

Some 5.4m people in the UK are currently receiving treatment for asthma, including more than a million children.

The allergic immune response, which triggers the symptoms of asthma, is a complex process, which starts with the over-activation of a certain white blood cell, the allergen-specific helper T cells type 2.

"We found that by adding a , Interleukin 1 (IL-1) using an experimental model of , the symptoms would worsen dramatically," explained Dr Caucheteux.

"Therefore by blocking production of IL-1, we could alleviate the symptoms, such as mucus, swelling and constriction."

The research, published in the Journal of Allergy and Clinical Immunology, also involved colleagues at the National Institutes of Health in the USA: Drs Jane Hu-Li, Liying Guo, Michelle Crank, Nisan Bhattacharyya and Michael Collins.

This research project was directed by the late William E Paul, Chief of the Laboratory of Immunology at the National Institute of Allergy and Infectious Diseases.

Dr Jeff Zhu, Chief of the Molecular and Cellular Immunoregulation Unit at the Laboratory of Immunology at the National Institute of Allergy and Infectious Diseases, said: "The finding that IL-1 is involved in regulating the balance between inflammatory and anti-inflammatory Th2 cells has not only significantly enhanced our basic knowledge on T cell biology, but also provided a potentially effective and novel strategy to treat asthma."

Explore further: Blanket approach to asthma treatment not ideal, researchers find

More information: Interleukin-1 beta enhances inflammatory Th2 differentiation; Stephan M. Caucheteux; The Journal of Allergy and Clinical Immunology; DOI: dx.doi.org/10.1016/j.jaci.2016.02.033

Related Stories

Holiday health: Asthma with a side of allergies

November 8, 2013

People with asthma traveling to pet friendly homes for the holidays may want to pack allergy medication along with their inhaler. A study being presented this week at the American College of Allergy, Asthma and Immunology's ...

New asthma biomarkers discovered, could ease detection

April 13, 2016

People with asthma have telltale molecules circulating in their blood, say researchers at Penn State College of Medicine. The discovery could lead to the first diagnostic blood test for asthma, as well as more targeted treatments ...

Recommended for you

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.